Welcome to our website!
Standard chemotherapy does not work as a standard instrument for all cancer patients. A targeted therapy for a few does not offer a solution either. In order to truly personalise the cancer therapy, it is necessary to have a powerful global marker – one that is able to answer the question as to which cancer therapy works for one patient and which does not. A marker of this kind requires an absolutely precise marker test.
The good news is: MARK53 represents both.
ABOUT 
With the Mark53 analysis, our company is making available a precise p53 gene test, which – for the first time – establishes the prerequisites for a broad clinical application of this biomarker. For the question, as to which patient responds to a cancer therapy and which does not, is a crucial one! We wish to pave the way for an efficient cancer therapy and continue to guarantee research that is independent of the pharmaceutical industry.